Clearline Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-519,340
Closed -$4.77M 145
2024
Q3
$4.77M Sell
519,340
-3,844,861
-88% -$31.8M 0.2% 69
2024
Q2
$42.7M Buy
4,364,201
+3,483,665
+396% +$42.5M 1.18% 5
2024
Q1
$13.3M Buy
+880,536
New +$16M 0.65% 24

Other funds holding TDOC

Clearline Capital's TDOC Position: Q4 2024 in Review

Clearline Capital sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 519,340 shares — an estimated $4.77M sold.

Clearline Capital first reported a position in TDOC in Q1 2024 and held it in 3 quarters. The position peaked at $42.7M in Q2 2024. 380 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Clearline Capital reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Clearline Capital sold 519,340 Teladoc Health shares in Q4 2024, an estimated $4.77M.
  • Clearline Capital first reported a position in Teladoc Health in Q1 2024 and held it in 3 quarters.
  • Clearline Capital's Teladoc Health position peaked at $42.7M in Q2 2024.
  • 380 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.